Desvenlafaxine 00591-3659
Product NDC
00591-3659- Manufacturer
- Actavis Pharma, Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 1, 2017
- Listing Expires
- December 31, 2026
- Application
- ANDA204065
Need to source Desvenlafaxine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Desvenlafaxine Succinate | 50 mg/1 |
Drug Class
Cytochrome P450 2D6 Inhibitors [MoA]Norepinephrine Uptake Inhibitors [MoA]Serotonin Uptake Inhibitors [MoA]
Packaging Options(1)
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-3659-30)